glp-1 postpartum From JAMA: prescription of #GLP-1RAs in Denmark increased between 2018 and 2024, with #semaglutide accounting for most prescriptions since 2023. Most users had #overweight or #obesity, and only 23% had a # Maternal cardiometabolic health and the

Some people report more stomach issues due to the dual-hormone action

However, given the uncertainty of the interruption interval of these medications, gastric ultrasound appears to be a crucial tool for identifying patients at high risk of pulmonary aspiration In summary, emerging evidence suggests that perioperative use of GLP-1RAs is associated with delayed gastric emptying and greater RGC, which in turn may increase the risk of pulmonary aspiration

The STEP 4 trial showed that participants who discontinued the medication regained two-thirds of their lost weight within a year

Moreover, SIRT-1-knockout POMC neurons were shown to exhibit reduced sympathetic nerve activity, UCP-1 expression, and brown fat-like activity in perigonadal WAT66)

Marks ability to investigate the matter further was, however, temporarily delayed by the fact that shortly after the conference Samols went to Seattle to spend a sabbatical year with Robert Williams to learn more about the clinical and laboratory aspects of diabetes (Marks 2018)